A trend promises the antidote to burnout and brain rot. There is some science to back it up. By Makaelah Walters Hannah Busby ...
KubeRay provides an open-source, Kubernetes-native operator that manages the complete lifecycle of Ray clusters, jobs, and ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
OpenIDEA 0.1.43 adds an allocation and live-object profiler for JVM runs, FTP/FTPS deployment, Django templates, notebook code intelligence, custom ACP agents with a command policy, Kotlin debugging, ...
MimeKit 5.0 is a major release containing a number of breaking changes. The headline changes are the split of the cryptography support into its own assembly, the promotion of the new MIME parser, a ...
Recent insider activity for Recursion Pharmaceuticals Inc included 1 Tax Payment by Ben R Taylor totaling $18,400.36. 1 transaction was reported, and the full verified total matches $18,400.36.
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results